MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

MDT

100.48

+1.87%↑

139.65

+3%↑

VEEV

219.8

+1.79%↑

HQY

84.32

+0.78%↑

NEOG

9.86

+5.45%↑

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Затворен

4.04 96.12

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.04

Максимум

4.06

Ключови измерители
By Trading Economics
Служители	26

Дивиденти
By Dow Jones
Следващи печалби	26.02.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-4.2M 16M
Предишно отваряне	-92.08
Предишно затваряне	4.04

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

20.01.2026 г., 23:43 ч. UTC

Пазарно говорене

Gold Consolidates; May Face Technical Correction -- Market Talk

20.01.2026 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Fall Amid Concerns Over U.S.-Europe Trade Relations -- Market Talk

20.01.2026 г., 23:41 ч. UTC

Печалби

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- 2nd Update

20.01.2026 г., 23:29 ч. UTC

Пазарно говорене

RBA Rate Hike in February Would Be a Painful One -- Market Talk

20.01.2026 г., 23:26 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

20.01.2026 г., 23:26 ч. UTC

Пазарно говорене

James Hardie Appeals More as Reece's U.S. Strategy Comes Under Scrutiny -- Market Talk

20.01.2026 г., 22:45 ч. UTC

Придобивния, сливания и поглъщания

ACCC: Ampol-EG Deal Is First Assessment Subject to Phase 2 Review Under New Merger Control Regime

20.01.2026 г., 22:45 ч. UTC

Придобивния, сливания и поглъщания

ACCC Seeks Submissions in Response to Phase 2 Notice by February 4

20.01.2026 г., 22:44 ч. UTC

Придобивния, сливания и поглъщания

ACCC: Ampol's Offer to Sell 19 Retail Fuel Sites Doesn't Adequately Address Issues

20.01.2026 г., 22:44 ч. UTC

Придобивния, сливания и поглъщания

ACCC Identifies 115 EG Sites Where Deal Could Substantially Lessen Competition

20.01.2026 г., 22:43 ч. UTC

Придобивния, сливания и поглъщания

ACCC Says Deal Could Substantially Lessen Competition in Retail Supply of Petrol, Diesel in Several Markets in Australia

20.01.2026 г., 22:43 ч. UTC

Придобивния, сливания и поглъщания

Ampol's Acquisition of EG Australia to Undergo In-Depth Review by Competition Regulator

20.01.2026 г., 22:27 ч. UTC

Придобивния, сливания и поглъщания

Netflix Plans to Roll Out New Mobile User Interface Later This Year, Co-CEO Says

20.01.2026 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

Netflix Co-CEO Sees Uptick in Engagement for TV-Based Games

20.01.2026 г., 22:21 ч. UTC

Придобивния, сливания и поглъщания

Netflix Would Keep 45-Day Theater Release Window for Warner Bros. Films, Co-CEO Says

20.01.2026 г., 22:20 ч. UTC

Придобивния, сливания и поглъщания

Netflix Excited to Strengthen Warner Bros.'s Theatrical-Distribution Business, Co-CEO Says

20.01.2026 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Netflix Pleased With Early Results for Podcasts, Co-CEO Says

20.01.2026 г., 22:18 ч. UTC

Печалби

Netflix Stock Is Falling. This Is Overshadowing the Streamer's Earnings Beat. -- Barrons.com

20.01.2026 г., 22:17 ч. UTC

Придобивния, сливания и поглъщания

Netflix's Live Events Are Boosting Retention, Co-CEO Says

20.01.2026 г., 22:16 ч. UTC

Придобивния, сливания и поглъщания

Netflix Remains 'Very Excited' About Live-Events Offering, Co-CEO Says

20.01.2026 г., 22:15 ч. UTC

Придобивния, сливания и поглъщания

Netflix's Proposed Deal for Warner Bros. Would Protect, Create Jobs, Co-CEO Says

20.01.2026 г., 22:15 ч. UTC

Придобивния, сливания и поглъщания

Netflix Competes for Attention Across Streaming, Broadcast, Cable, Gaming, Social Media, Video Platforms, Co-CEO Says

20.01.2026 г., 22:13 ч. UTC

Придобивния, сливания и поглъщания

Netflix Co-CEO: TV Landscape Has Never Been More Competitive

20.01.2026 г., 22:11 ч. UTC

Придобивния, сливания и поглъщания

Netflix Confident Warner Bros. Deal Would Pass Regulatory Review, Co-CEO Says

20.01.2026 г., 22:10 ч. UTC

Придобивния, сливания и поглъщания

Netflix Would Leverage Global Footprint, Streaming Expertise to Improve Warner Bros.'s HBO Max Service, Co-CEO Says

20.01.2026 г., 22:08 ч. UTC

Придобивния, сливания и поглъщания

Netflix Won't Raise Prices During Regulatory-Review Process for Pending Warner Bros. Deal, Co-CEO Says

20.01.2026 г., 22:07 ч. UTC

Придобивния, сливания и поглъщания

Netflix Sees Warner Bros. as Another Mechanism to Improve Offerings, Co-CEO Says

20.01.2026 г., 22:06 ч. UTC

Печалби

Netflix Revenue and Profit Rise as Subscriptions Top 325 Million -- Update

20.01.2026 г., 22:00 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

ESG Roundup: Market Talk

20.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Tech, Media & Telecom Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.